AWHP CEO Millicent Gorham comments on the Ohio Department of Administrative Services to end state employees’ coverage of obesity management medications.

AWHP CEO Millicent Gorham’s oral comments to ACIP were featured in JAMA Medical News.

AWHP CEO Millicent Gorham provided oral comments at the June 2025 ACIP meeting.

AWHP CEO Millicent Gorham’s op-ed on comprehensive obesity care appeared in the Washington Post.

AWHP CEO Millicent Gorham comments on CMS’ decision not to finalize a proposed rule that would have required coverage of GLP-1s under Medicare Part D and Medicaid.

AWHP CEO Millicent Gorham comments on CMS’ decision not to finalize a rule that would have included coverage for obesity medications through Medicare Part D and Medicaid.

AWHP CEO Millicent Gorham comments on how coverage for obesity medications can boost workplace productivity.

AWHP and other organizations urged employers to cover the “full range of evidence-based obesity care options,” including medical nutrition therapy, intensive behavioral therapy, surgery and medications.

AWHP’s letter led a letter pushing employers to cover obesity the same way they would for any other chronic disease.